GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets

NACompletedINTERVENTIONAL
Enrollment

386

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions
Type 2 Diabetes Mellitus
Interventions
BEHAVIORAL

Education of general practitioners on the IDF-WPR guidelines

"The intervention will comprise an educational program on the guidelines for GPs, and will be carried out by the national coordinating centre in each country, based on a template provided by the international coordinating centre (International Diabetes Institute, Australia). This will involve:~an initial educational symposium and a follow-up continuing medical education symposium at 3 months; paper or electronic reminders of the guidelines sent to GPs every 3 months; desktop reminder cards with guideline algorithms; insertion of a flowsheet (diabetes action plan) into the patient's medical notes by the study nurse; provision of each patient with a diabetes passport to be held by the patient."

Trial Locations (10)

10400

Diabetes and Endocrinology Unit, Department of Medicine, Rajavithi Hospital,, Bangkok

60286

Diabetes and Nutrition Center, Dr. Soetomo Teaching Hospital - Airlangga University,, Surabaya

80100

School of Medicine and Health Sciences, Monash University House, Johor Bahru

100044

Department of Endocrinology & Metabolism, Peking University People's Hospital, Beijing

258499

Diabetes, Lipid and Endocrine Practice, Gleneagles Medical Centre, Singapore

Unknown

Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin

Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of the Philippines College of Medicine, Manila

Department of Endocrinology & Metabolism, Kangnam St. Mary's Hospital, The Catholic University of Medicine, Seoul

Dept of Medical Research and Education, Taipei Veterans General Hospital,, Taipei

National Hospital of Endocrinology,, Hanoi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

International Diabetes Institute, Australia

OTHER